Convulsions Associated with the Use of a Synthetic Cannabinoid Product.

01:40 EDT 26th May 2015 | BioPortfolio

Summary of "Convulsions Associated with the Use of a Synthetic Cannabinoid Product."


INTRODUCTION:
Clinical presentations following the use of various "spice" or synthetic cannabinoids have included agitation, anxiety, emesis, hallucinations, psychosis, tachycardia, and unresponsiveness. Convulsions were described in a one report although there was not laboratory confirmation for synthetic cannabinoids. In another published report laboratory confirmation for a synthetic cannabinoid was done in which the patient manifested activity that was interpreted as a possible convulsion. CASE
REPORT:
We describe a patient who had two witnessed generalized convulsions soon after smoking a "spice" product that we later confirmed to have four different synthetic cannabinoids.
DISCUSSION:
Convulsions have only rarely been associated with marijuana exposures. Recreational use of synthetic cannabinoids is a very recent phenomenon and there is a very limited, albeit burgeoning, literature detailing the associated complications including convulsions we have reported here. The absence of anticonvulsant phytocannabinoids in spice products could potentially be one of multiple unknown mechanisms contributing to convulsions.

Affiliation

Division of Medical Toxicology, Department of Emergency Medicine, University of California, San Diego Medical Center, 200 West Arbor Drive #8925, San Diego, CA, 92103, USA, aschneir@ucsd.edu.

Journal Details

This article was published in the following journal.

Name: Journal of medical toxicology : official journal of the American College of Medical Toxicology
ISSN: 1937-6995
Pages:

Links

PubMed Articles [4909 Associated PubMed Articles listed on BioPortfolio]

Detection of the synthetic cannabinoid JWH-210 in the Valencia region.

The Influence of Synthetic Cannabinoid UR-144 on Human Psychomotor Performance - A Case Report Demonstrating Road Traffic Risks.

UR-144 [(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone] is a synthetic cannabinoid, which has been detected in many 'legal highs' seized from the global drug market since the begin...

In Process Citation.

Synthetic cannabinoids are a large group of chemicals functionally related to delta-9-tetrahydrocannabinol (THC) found in Cannabis sativa. These compounds are full agonists on cannabinoid receptors, t...

Synthesis of the Spirocyclic Framework of Sesterterpenoid Natural Products.

A convergent synthetic route to the sesterterpenoid framework of the bioactive phorbaketal and alotaketal natural product families has been established. The synthetic approach hinges on a Hosomi-Sakur...

CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.

Synthetic cannabinoid designer drugs have emerged as drugs of abuse during the last decade, and acute intoxication cases are documented in the scientific literature. Synthetic cannabinoids are extensi...

Clinical Trials [851 Associated Clinical Trials listed on BioPortfolio]

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

The overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system. This will be tested by studying individuals with a...

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

This study is a trial of dexanabinol in patients with advanced tumours. The purposes of the protocol are to study different doses of the study drug to determine the maximum safe dose of t...

Deep Brain Stimulation Effects Study

The purpose of this study is to provide proof-of-concept that the test product can perform as intended in an intra-operative setting and the responses to the test product are perceivable i...

Lindi Product Satisfaction Survey

This study is being done because the investigators would like to evaluate product satisfaction of three test products (product A, product B, product C) that are available at any drug store...

Comparasion of Two Urostomy Bags (2-Piece).

Coloplast A/S has developed a new, improved two-piece product for people with urostomies. This 2-piece product is a part of a new product family, under the brand name SenSura. The aim of t...

Medical and Biotech [MESH] Definitions

A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.

A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.

Form in which product is processed or wrapped and labeled. PRODUCT LABELING is also available.

Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA.

Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Psychiatry
Latest News Clinical Trials Research Drugs Reports Corporate
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Advertisement

Searches Linking to this Article